Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michio Nagaoka"'
Autor:
Ikuto Masakane, Ichiro Yamaguchi, Yuji Matsumoto, Ken Ataka, Yuta Oyama, Michio Nagaoka, Yasushi Matsushita, Tomoko Teramura, Koji Seino, Hiroyuki Amano, Ai Kobayashi
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background Malnutrition that is associated with inflammation is a key factor of poor outcome in chronic hemodialysis patients, especially in older dialysis patients. Polymethyl methacrylate (PMMA) membrane has been reported to improve the in
Externí odkaz:
https://doaj.org/article/fff8051a8d574f348c91bb528ec18b28
Autor:
Yasushi Matsushita, Ken Ataka, Koji Seino, Ichiro Yamaguchi, Yuta Oyama, Tomoko Teramura, Michio Nagaoka, Ikuto Masakane, Ai Kobayashi, Hiroyuki Amano, Yuji Matsumoto
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-10 (2021)
Background Malnutrition that is associated with inflammation is a key factor of poor outcome in chronic hemodialysis patients, especially in older dialysis patients. Polymethyl methacrylate (PMMA) membrane has been reported to improve the inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19147a95b817a1f7c72b1da3ec1bce44
https://doaj.org/article/fff8051a8d574f348c91bb528ec18b28
https://doaj.org/article/fff8051a8d574f348c91bb528ec18b28
Autor:
Mio Ueda, Minako Akiyama, Shinnichi Iwai, Miho Nagai, Eiichiro Kanda, Yume Nagaoka, Yoshihiko Kanno, Michio Nagaoka, Rie Suzuki, Kakei Ryu, Yoshitaka Miyaoka, Yoshiko Tanaka, Hiroshi Yoshimoto
Publikováno v:
Hemodialysis International. 22:388-393
Introduction: Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f3d24543183ebe2cdeb34309cc8430
https://doi.org/10.1111/hdi.12620
https://doi.org/10.1111/hdi.12620
Autor:
Yume, Nagaoka, Yoshiko, Tanaka, Hiroshi, Yoshimoto, Rie, Suzuki, Kakei, Ryu, Mio, Ueda, Minako, Akiyama, Miho, Nagai, Yoshitaka, Miyaoka, Eiichiro, Kanda, Shinnichi, Iwai, Michio, Nagaoka, Yoshihiko, Kanno
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 22(3)
Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been established in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3a130eacddfd02b2e84617c8b58ad32
https://pubmed.ncbi.nlm.nih.gov/29227568
https://pubmed.ncbi.nlm.nih.gov/29227568
Autor:
Yume NAGAOKA, Yoshiko TANAKA, Hiroshi YOSHIMOTO, Rie SUZUKI, Kakei RYU, Mio UEDA, Minako AKIYAMA, Miho NAGAI, Yoshitaka MIYAOKA, Eiichiro KANDA, Shinnichi IWAI, Michio NAGAOKA, Yoshihiko KANNO
Publikováno v:
Home Hemodialysis International; Jul2018, Vol. 22 Issue 3, p388-393, 6p
Autor:
Yume Nagaoka, Yoshiko Tanaka, Hiroshi Yoshimoto, Rie Suzuki, Mio Ueda, Minako Akiyama, Miho Nagai, Yoshitaka Miyaoka, Eiichiro Kanda, Michio Nagaoka, Yoshihiko Kanno
Publikováno v:
GOUT AND NUCLEIC ACID METABOLISM. 40:102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c5903191cf74cf1dfe112f9399c0f49
https://doi.org/10.6032/gnam.40.102
https://doi.org/10.6032/gnam.40.102
Publikováno v:
Japanese Journal of Radiological Technology. 43:1313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4da2f553e0e5fec7debff3f4d009d86
https://doi.org/10.6009/jjrt.kj00001363715
https://doi.org/10.6009/jjrt.kj00001363715